Grisham J W, Greenberg D S, Kaufman D G, Smith G J
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4813-7. doi: 10.1073/pnas.77.8.4813.
Exposure of C3H 10T1/2 Cl 8 cells, synchronized by release from confluence-induced arest of proliferation, to different concentrations of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) for 30 min at various points during the cell cycle causes dose-dependent toxicity (decrease in relative colony-forming efficiency or "survival") that increases linearly during the first G1 phase, reaches a maximum in early to middle S phase, and decreases during late S. In the course of the second S phase, toxicity again becomes maximal. The transformation rate (type III foci) increases and decreases with a similar pattern, increasing during the first G1 phase to a maximum during early S phase, subsequently decreasing, and then increasing again during the second S phase. Although periods of maximal toxicity and transformation roughly coincide with some portion of the S phase, the mechanisms underlying these phenomena appear to differ for the following reasons: (a) toxicity is linearly related to dose of MNNG, whereas the latter is linearly related to the logarithm of transformation rate, and (b) the ratio between toxicity and transformation varies with the cycle phase and the dose of MNNG.
通过从汇合诱导的增殖停滞中释放来同步化的C3H 10T1/2 Cl 8细胞,在细胞周期的不同时间点暴露于不同浓度的N-甲基-N'-硝基-N-亚硝基胍(MNNG)30分钟,会导致剂量依赖性毒性(相对集落形成效率或“存活率”降低),这种毒性在第一个G1期呈线性增加,在早S期至中S期达到最大值,并在晚S期降低。在第二个S期过程中,毒性再次达到最大值。转化频率(III型病灶)以类似模式增加和降低,在第一个G1期增加,在早S期达到最大值,随后降低,然后在第二个S期再次增加。尽管最大毒性期和转化期大致与S期的某些部分重合,但由于以下原因,这些现象背后的机制似乎有所不同:(a)毒性与MNNG剂量呈线性关系,而后者与转化频率的对数呈线性关系,(b)毒性与转化之间的比率随细胞周期阶段和MNNG剂量而变化。